Toward neuroprotective treatments of Parkinson's disease

被引:23
|
作者
Kim, Kwang-Soo [1 ,2 ]
机构
[1] Harvard Med Sch, Program Neurosci, Mol Neurobiol Lab, Boston, MA 02115 USA
[2] Harvard Med Sch, McLean Hosp, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA
关键词
DOPAMINE NEURONS; NUCLEAR RECEPTORS; NURR1; PATHWAY; MODELS;
D O I
10.1073/pnas.1703362114
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:3795 / 3797
页数:3
相关论文
共 50 条
  • [41] THE NEUROPROTECTIVE MECHANISMS OF ACUPUNCTURE TREATMENT IN PARKINSON'S DISEASE
    Park, Hi-Joon
    Kim, Seung-Tae
    Moon, Woongjoon
    Kim, Seung-Nam
    Chae, Younbyoung
    Lee, Hyejung
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 51 - 51
  • [42] Disease process and drug treatments in Parkinson's disease
    Leenders, KL
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 (06) : 575 - 580
  • [43] Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
    Mythri, R. B.
    Bharath, M. M. Srinivas
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (01) : 91 - 99
  • [44] Neuroprotective actions of sex steroids in Parkinson's disease
    Bourque, Melanie
    Dluzen, Dean E.
    Di Paolo, Therese
    FRONTIERS IN NEUROENDOCRINOLOGY, 2009, 30 (02) : 142 - 157
  • [45] Dietary modifications in Parkinson's disease: A neuroprotective intervention?
    Shah, Shital P.
    Duda, John E.
    MEDICAL HYPOTHESES, 2015, 85 (06) : 1002 - 1005
  • [46] In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease
    Ridder, Dirk A.
    Schwaninger, Markus
    EXPERIMENTAL NEUROLOGY, 2012, 238 (02) : 133 - 137
  • [47] Nicotine as a potential neuroprotective agent for Parkinson's disease
    Quik, Maryka
    Perez, Xiomara A.
    Bordia, Tanuja
    MOVEMENT DISORDERS, 2012, 27 (08) : 947 - 957
  • [48] Amiloride is neuroprotective in an MPTP model of Parkinson's disease
    Arias, Robert L.
    Sung, Mei-Li A.
    Vasylyev, Dmytro
    Zhang, Mei-Yi
    Albinson, Kristin
    Kubek, Katie
    Kagan, Natasha
    Beyer, Chad
    Lin, Qian
    Dwyer, Jason M.
    Zaleska, Margaret M.
    Bowlby, Mark R.
    Dunlop, John
    Monaghan, Michael
    NEUROBIOLOGY OF DISEASE, 2008, 31 (03) : 334 - 341
  • [49] Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease
    Olson, Katherine E.
    Gendelman, Howard E.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 26 : 87 - 95
  • [50] Symptomatic and neuroprotective effect of rTMS in Parkinson's disease
    Maly, J.
    Stone, T. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 101 - 101